Plasma Hypercoagulability Is Correlated to Plasma HIV Load*

Thromb Haemost 1998; 80(01): 208-209
DOI: 10.1055/s-0037-1615171

Letters to the Editor

Schattauer GmbH

Marina Karmochkine

¹Service de Médecine Interne

,

Annick Ankri

²Laboratoire d’Hématologie

,

Vincent Calvez

³Laboratoire de Virologie, Hôpital de la Pitié-Salpêtrière, Paris, France

,

Manuela Bonmarchant

¹Service de Médecine Interne

,

Anne Coutellier

¹Service de Médecine Interne

,

Serge Herson

¹Service de Médecine Interne

References
1 Brew BJ, Miller J. Human immunodeficiency virus type 1-related transient neurological deficits.. Am J Med 1996; 101: 257-61.
2 Cohen JR, Lackner R, Wenig P, Pillari G. Deep venous thrombosis in patients with AIDS.. NY State J Med 1990; 90: 159-61.
3 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of the hemostatic system activation.. Blood 1987; 70: 343-50.
4 Manucci PM, Tripodi A, Bottasso B, Baudo F, Finazzi G, De Stefano V, Palareti G, Manotti C, Mazzucconi MG, Castaman G. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes.. Thromb Haemost 1992; 67: 200-2.
5 Boffa MC. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker.. Hemostasis 1996; 26 (Suppl. 04) 233-43.
6 Carr A, Brown D, Cooper DA. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.. AIDS 1998; 11: 1657-8.